Back
Bristol-Myers Squibb Vs. Gilead Sciences Industry Stock Comparison
Buy
60
BMY
Bristol-Myers Squibb
Last Price:
50.40
Seasonality Move:
1.06%
Sell
49
GILD
Gilead Sciences
Last Price:
77.01
Seasonality Move:
9.03%
Buy
60
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $45.27. The Score for BMY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Gilead Sciences (GILD)
is a Sell
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $76.53. The Score for GILD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- GILD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $45.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing slight buying pressure.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $76.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GILD is experiencing slight buying pressure.
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 69.78 | Buy |
| Chaikin Money Flow: | 1189228 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.34 - 43.08) | Buy |
| Bollinger Bands (100): | (41.02 - 50.36) | Sell |
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.87 | Buy |
| Relative Strength Index (14 RSI): | 72.98 | Buy |
| Chaikin Money Flow: | 4558530 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.87 - 72.61) | Buy |
| Bollinger Bands (100): | (65.2 - 72.24) | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.12 | Buy |
| 20-day SMA: | 41.64 | Buy |
| 50-day SMA: | 41.85 | Buy |
| 200-day SMA: | 48.49 | Sell |
| 8-day EMA: | 43.3 | Buy |
| 20-day EMA: | 42.3 | Buy |
| 50-day EMA: | 42.73 | Buy |
| 200-day EMA: | 48.82 | Sell |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.08 | Buy |
| 20-day SMA: | 70.36 | Buy |
| 50-day SMA: | 67.75 | Buy |
| 200-day SMA: | 73.48 | Buy |
| 8-day EMA: | 73.01 | Buy |
| 20-day EMA: | 70.98 | Buy |
| 50-day EMA: | 69.16 | Buy |
| 200-day EMA: | 71.9 | Buy |
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.21 per share, a decrease this year of $6.88 per share, and an increase next year of $6.37 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.06 per share, a decrease this year of $3.05 per share, and an increase next year of $3.42 per share.
Bristol-Myers Squibb Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gilead Sciences Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||